2024-11-09 - Analysis Report
## Eli Lilly and Co (LLY) Stock Analysis Report 

**1. Performance Comparison:**

Eli Lilly and Co (LLY) has significantly outperformed the S&P 500 (VOO) with a cumulative return of 752.03% compared to VOO's 141.71%. The current divergence is 610.32%, which represents 76.28% of the historical maximum divergence range.  

**Alpha and Beta Analysis:**

| Year | CAGR | MDD | Alpha | Beta |
|---|---|---|---|---|
| 2015-2017 | 20.6% | 19.6% | -9.6% | 0.8 |
| 2016-2018 | 39.6% | 19.2% | 14.9% | 0.7 |
| 2017-2019 | 76.2% | 17.2% | 33.1% | 0.7 |
| 2018-2020 | 99.4% | 22.1% | 60.3% | 0.7 |
| 2019-2021 | 140.4% | 22.1% | 50.6% | 0.7 |
| 2020-2022 | 176.7% | 22.1% | 159.0% | 0.7 |
| 2021-2023 | 252.2% | 18.6% | 223.4% | 0.5 |
| 2022-2024 | 193.5% | 19.0% | 168.8% | 0.6 |

This analysis suggests that LLY has consistently outperformed the market, with strong alpha and a beta close to 0.7, indicating its sensitivity to market movements.

**2. Recent Price Movement:**

* **Closing Price:** 797.45 (Last-market: 839.73)
* **5-day Moving Average:** 800.99
* **20-day Moving Average:** 875.48
* **60-day Moving Average:** 905.97

The current price is below all moving averages, suggesting a potential downward trend in the short term. The last market price indicates a recent bounce. 

**3. Technical Indicators:**

* **RSI:** 18.81 -  This indicates oversold conditions, suggesting a potential for a bounce.
* **PPO:** -1.35 - This indicates a bearish trend, consistent with the RSI reading.
* **Delta_Previous_Relative_Divergence:** -15.87 (-) - This indicates a short-term downward trend.
* **Expected Return:** 98.22% - This represents the expected long-term (2 years+) excess return compared to the S&P 500.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-10-30 | 1.08 | 11.44 B$ |
| 2024-08-08 | 3.29 | 11.30 B$ |
| 2024-04-30 | 2.49 | 8.77 B$ |
| 2023-11-02 | -0.06 | 9.50 B$ |
| 2024-10-30 | -0.06 | 9.50 B$ |

The latest earnings report on October 30th, 2024 showed an EPS of 1.08, exceeding analysts' expectations.  This indicates a positive trend in LLY's performance.

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---|---|---|
| 2024-09-30 | $11.44B | 81.02% |
| 2024-06-30 | $11.30B | 80.80% |
| 2024-03-31 | $8.77B | 80.91% |
| 2023-12-31 | $9.35B | 80.88% |
| 2023-09-30 | $9.50B | 80.42% |

**Capital and Profitability:**

| Quarter | Equity | ROE |
|---|---|---|
| 2024-09-30 | $14.24B | 6.81% |
| 2024-06-30 | $13.56B | 21.88% |
| 2024-03-31 | $12.81B | 17.51% |
| 2023-12-31 | $10.77B | 20.33% |
| 2023-09-30 | $11.22B | -0.51% |

LLY demonstrates strong profitability with high profit margins and healthy ROE, indicating efficient capital utilization.

**6. News and Recent Issues:**

* **Recent Earnings News:** Analyze recent earnings reports released within the last two days from reputable sources like Shacknews and others. 
* **Recent Market Outlook:** Look for recent analysis from FINBOLD and other financial news outlets. Identify any recent market events affecting LLY's stock price. 
* **Analyst Opinions and Performance Highlights:** Gather insights from recent analyst ratings and reports, paying attention to their target prices and sentiments towards LLY.

**7. Overall Analysis:**

Eli Lilly and Co (LLY) has shown consistent outperformance compared to the S&P 500 with a strong long-term growth potential. Recent earnings reports indicate positive performance with a healthy financial outlook.  The technical indicators suggest oversold conditions and potential for a short-term bounce.  However, the current price movement remains below all moving averages, indicating a potential for a continued downward trend in the short term.  Overall, LLY remains a promising investment for long-term investors seeking robust growth opportunities. 

**Please note:** This analysis is based on the provided data and does not constitute financial advice. Always conduct thorough research and consult with a financial advisor before making any investment decisions. 
